Sana Biotechnology Inc
Follow $SANA
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $SANA by emailVeridion Score
BETALOW CONF · 4 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is SANA moving today?
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
SANA overview
Related filings and maps
Congress activity in SANA
No receipt-qualified Congressional disclosure is present for SANA in the cached public ledger.
SANA contract awards, year to date.
Public federal awards linked to this ticker.
SANA lobbying filings, year to date.
Registered lobbying filings matched to Sana Biotechnology Inc.